 |
|
Herpesvirus: To Vaccinate or Not To Vaccinate Scientists Weigh Risks and Benefits
February 13, 2009Dr. Marcia Blackman and her research team at the Trudeau Institute have followed up on an intriguing report(1)published in the journal Nature in May 2007 by Dr. Herbert Virgin, et al., showing that mice persistently infected with certain forms of herpesvirus, which can establish lifelong latent infections, are resistant to infection with bacterial pathogens.
Although herpesvirus infections are generally considered undesirable and can be associated with declining immune function in the elderly or the development of a variety of tumors later in life, the Virgin report raised the unexpected possibility that they may also be beneficial.
Dr. Blackman's research has now confirmed Dr. Virgin's findings, but with some further refinements about herpes' roles in preventing other infections: "We discovered that the effect of herpesvirus infection is transient, lasting only a few months. Interestingly, although the effect was shown by the Virgin group to be dependent on establishing a latent infection, it wanes despite lifelong latency."
Recognizing that her data had implications for the interpretation of Dr. Virgin's data, Dr. Blackman shared her findings with the Virgin group prior to publication. This led to an interesting exchange between the two labs in the form of letters to the editor regarding the potential benefits of a transient protective effect. The letters will be published concurrently with Blackman's data in the February issue of Viral Immunology (Vol. 22, No.1). The scientists agree that even short-acting protection, especially during childhood, might have long-lasting implications in terms of survival rates.
A major point of discussion between the two groups concerned the implications of such research for the development of vaccines against herpesvirus infections. Dr. Virgin suggested that "decreased infection may be associated with unintended negative consequences for vaccinated individuals." In response, Dr. Blackman argues that possible transient protective effects did not outweigh the already recognized pathological consequences of herpesvirus infection. Both groups agreed that the protective effects of herpesvirus infections merit further study.
Importantly, both groups hope their observations will stimulate epidemiological and clinical studies to determine whether herpesvirus infections really protect humans against bacterial diseases.
(1)"Herpesvirus latency confers symbiotic protection from bacterial infection," NATURE, Vol. 447, pp. 326-29; May 17, 2007.
The Trudeau Institute
Recognizing that her data had implications for the interpretation of Dr. Virgin's data, Dr. Blackman shared her findings with the Virgin group prior to publication. This led to an interesting exchange between the two labs in the form of letters to the editor regarding the potential benefits of a transient protective effect. The letters will be published concurrently with Blackman's data in the February issue of Viral Immunology (Vol. 22, No.1). The scientists agree that even short-acting protection, especially during childhood, might have long-lasting implications in terms of survival rates.
A major point of discussion between the two groups concerned the implications of such research for the development of vaccines against herpesvirus infections. Dr. Virgin suggested that "decreased infection may be associated with unintended negative consequences for vaccinated individuals." In response, Dr. Blackman argues that possible transient protective effects did not outweigh the already recognized pathological consequences of herpesvirus infection. Both groups agreed that the protective effects of herpesvirus infections merit further study.
Importantly, both groups hope their observations will stimulate epidemiological and clinical studies to determine whether herpesvirus infections really protect humans against bacterial diseases.
(1)"Herpesvirus latency confers symbiotic protection from bacterial infection," NATURE, Vol. 447, pp. 326-29; May 17, 2007.
The Trudeau Institute
Herpesvirus Current Events and Herpesvirus News RSSResearch uncovers clues to virus-cancer link
In a series of recently-published articles, a research team from the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center has uncovered clues to the development of cancers in AIDS patients.
OHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.
Researchers report the cloning of a key group of human genes, the protein kinases
Although the human genome has been sequenced, research into mechanism of action of genes has been hampered by the fact that most human genes have not been isolated. This is true for even the most common class of cancer-associated genes, the protein kinases, which mediate the majority of signaling events in cells by phosphorylating and modulating the activity of other proteins.
Study proposes new theory of how viruses may contribute to cancer
A new study suggests that viruses may contribute to cancer by causing excessive death to normal cells while promoting the growth of surviving cells with cancerous traits.
Kaposi sarcoma arises independently from multiple cells
Kaposi sarcoma is unique among cancers because most tumors grow from a small number of different cells, whereas nearly all other cancers arise from a single cell.
UF scientists identify cancer virus' genetic targets
University of Florida researchers have identified specific human genes targeted by a virus believed to cause Kaposi's sarcoma, a rare form of cancer associated with AIDS and with organ transplants that causes patches of red or purple tissue to grow under people's skin.
Finnish scientists discovered a new approach to treat virus-induced lymphomas
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL).
An AIDS-related virus tricks cells to become tumors, new Penn study finds
Researchers at the University of Pennsylvania School of Medicine have discovered how the Kaposi's sarcoma-associated herpesvirus (KSHV) subverts a normal cell process in order to promote tumor growth.
Inhibition of iron-metabolizing enzyme reduces tumor growth
A report in the Journal of Biological Chemistry shows that inhibition of heme oxygenase-1, an enzyme involved in iron metabolism, reduces Kaposi sarcoma tumor growth.
Landmark discovery of a Kaposi's sarcoma-associated herpesvirus receptor
Researchers at the National Institute of Allergy and Infectious Disease (NIAID), a component of the National Institutes of Health (NIH), have identified a critical human cell surface molecule involved in infection by Kaposi's sarcoma herpesvirus (KSHV), the virus that causes Kaposi's sarcoma and certain forms of lymphoma.
More Herpesvirus Current Events and Herpesvirus News Articles
 |
Latency Strategies of Herpesviruses by Janos Minarovits (Editor), Eva Gonczol (Editor), Tibor Valyi-Nagy (Editor) This volume provides an overview of the latency strategies developed during the estimated 200 Myears long coevolution of Alpha-, Beta- and Gammaherpesvirinae and their host species. The main emphasis is on herpesviruses infecting humans. However, relevant cases if herpesviruses infecting animals are covered as well. Special emphasis is drawn on results on molecular mechanisms regulating latent promoters of herpesvirus genomes and signals and molecular pathways resulting in reactivation of latent viral genomes. To balance the volume, epigenetic mechanisms (DNA methylation, histone modification, chromatin structure) involved in cell type specific expression of growth-transformation-associated Gammaherpesvirus genes will also be discussed at length) |
 |
Rat Monoclonal Antibody to ORF-73 of Human Herpesvirus 8 (HHV-8) (100 µg) by Advanced Biotech Rat monoclonal antibody to latent nuclear antigen (LNA-1) ORF-73 of human herpesvirus 8 (HHV-8). This antibody originates from ascitic fluid and is purified by protein G agarose chromatography. |
 |
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis by Ann Arvin (Editor), Gabriella Campadelli-Fiume (Editor), Edward Mocarski (Editor), Patrick S. Moore (Editor), Bernard Roizman (Editor), Richard Whitley (Editor), Koichi Yamanishi (Editor) This definitive and comprehensive account of the human herpes viruses provides an encyclopedic overview of their basic virology and clinical manifestations. This group of viruses includes human simplex type 1 and 2, Epstein Barr virus, cytomegalovirus and varicella-zoster virus. The diseases they cause are significant and often recurrent. Their prevalence in the developed world accounts for a major burden of disease, and as a result there is a great deal of research into the pathophysiology if infection and immunobiology. Another important area covered within this volume concerns antiviral therapy and the development of vaccines. All these aspects are covered in depth and the volume is fully up to date both scientifically and in terms of clinical guidelines for patient care. The text is... |
 |
Interactions Between Retroviruses and Herpesviruses by H. J. Kung (Author) Retroviruses and herpesviruses are two common human pathogens. Co-infections of these two viruses in the same individuals are frequently observed, especially in patients afflicted with AIDS. Potential consequences of such interactions include the exacerbration of the disease, changing the disease courses and the release of new viruses. Understanding the underlying mechanism is important, but, thus far, few insights have been gained. The present monograph is intended to provide an updated and concise review of recent work regarding the molecular and cellular mechanisms of such interactions. The topics covered range from transcriptional regulation, receptor modulation and genetic recombination to AIDS and oncogenesis. Human immunodeficiency virus, avian leukosis virus, reticuloendotheliosis... |
 |
Kaposi Sarcoma Herpesvirus: New Perspectives (Current Topics in Microbiology and Immunology) by C. Boshoff (Editor), R.A. Weiss (Editor) |
|
Experts list top articles in infectious disease: herpesvirus infections, meningococcal vaccines, GBS disease, and varicella were hot topics.(Infectious Diseases): An article from: Pediatric News by Sherry Boschert (Author) This digital document is an article from Pediatric News, published by Thomson Gale on February 1, 2006. The length of the article is 1148 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Experts list top articles in infectious disease: herpesvirus infections, meningococcal vaccines, GBS disease, and varicella were hot topics.(Infectious Diseases) Author: Sherry Boschert Publication: Pediatric News (Magazine/Journal) Date: February 1, 2006 Publisher: Thomson Gale Volume: 40 Issue: 2 Page: 20(1) Distributed by Thomson... | |
|
Herpesvirus: Clinical, Pharmacological and Basic Aspects - International Symposium Proceedings (International congress series) by Hiroshi Shiota (Editor), etc. (Editor) | |
|
Human herpesvirus 8 and pulmonary hypertension.(DISPATCHES): An article from: Emerging Infectious Diseases by Emanuele Nicastri (Author), Carmine Dario Vizza (Author), Fabrizio Carletti (Author), Stefania Cicalini (Author), Roberto Badagliacca (Author), Roberto Poscia (Author), Giuseppe Ippolito (Author), Francesco Fedele (Author), Nicola Petrosillo (Author) This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on September 1, 2005. The length of the article is 2008 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Human herpesvirus 8 and pulmonary hypertension.(DISPATCHES) Author: Emanuele Nicastri Publication: Emerging Infectious Diseases (Magazine/Journal) Date: September 1, 2005 Publisher: Thomson Gale Volume: 11 Issue: 9 Page: 1480(3) Distributed by Thomson... | |
 |
Genetic Analysis Of Herpesvirus Entry Receptors And Host Susceptibility To Herpes Simplex Virus Infection (Acta Biomedica Lovaniensia) by Frank Struyf (Author) |
|
Herpesvirus, III: Recent Studies by Lajos, L. Donner, Yechiel Becker, et al Gergely (Author) |
| © 2009 BrightSurf.com |